BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 14693160)

  • 1. AMG531 stimulates megakaryopoiesis in vitro by binding to Mpl.
    Broudy VC; Lin NL
    Cytokine; 2004 Jan; 25(2):52-60. PubMed ID: 14693160
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thrombopoietin, but not cytokines binding to gp130 protein-coupled receptors, activates MAPKp42/44, AKT, and STAT proteins in normal human CD34+ cells, megakaryocytes, and platelets.
    Majka M; Ratajczak J; Villaire G; Kubiczek K; Marquez LA; Janowska-Wieczorek A; Ratajczak MZ
    Exp Hematol; 2002 Jul; 30(7):751-60. PubMed ID: 12135673
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential signalling of NH2-terminal flag-labelled thrombopoietin receptor activated by TPO or anti-FLAG antibodies.
    Millot GA; Vainchenker W; Duménil D; Svinarchuk F
    Cell Signal; 2004 Mar; 16(3):355-63. PubMed ID: 14687665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thrombopoietin activates a STAT5-like factor in hematopoietic cells.
    Pallard C; Gouilleux F; Bénit L; Cocault L; Souyri M; Levy D; Groner B; Gisselbrecht S; Dusanter-Fourt I
    EMBO J; 1995 Jun; 14(12):2847-56. PubMed ID: 7796811
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thrombopoietin stimulates colony-forming unit-megakaryocyte proliferation and megakaryocyte maturation independently of cytokines that signal through the gp130 receptor subunit.
    Broudy VC; Lin NL; Fox N; Taga T; Saito M; Kaushansky K
    Blood; 1996 Sep; 88(6):2026-32. PubMed ID: 8822921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lnk inhibits Tpo-mpl signaling and Tpo-mediated megakaryocytopoiesis.
    Tong W; Lodish HF
    J Exp Med; 2004 Sep; 200(5):569-80. PubMed ID: 15337790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Establishment and characterization of the thrombopoietin-dependent megakaryocytic cell line, UT-7/TPO.
    Komatsu N; Kunitama M; Yamada M; Hagiwara T; Kato T; Miyazaki H; Eguchi M; Yamamoto M; Miura Y
    Blood; 1996 Jun; 87(11):4552-60. PubMed ID: 8639823
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Involvement of prolonged ras activation in thrombopoietin-induced megakaryocytic differentiation of a human factor-dependent hematopoietic cell line.
    Matsumura I; Nakajima K; Wakao H; Hattori S; Hashimoto K; Sugahara H; Kato T; Miyazaki H; Hirano T; Kanakura Y
    Mol Cell Biol; 1998 Jul; 18(7):4282-90. PubMed ID: 9632812
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Promegapoietin, a family of chimeric growth factors, supports megakaryocyte development through activation of IL-3 and c-Mpl ligand signaling pathways.
    Doshi PD; Giri JG; Abegg AL; Favara JP; Huynh MS; Kahn LE; Minnerly JC; Pegg LE; Villani-Price D; Siegel NR; Staten NR; Thomas JW; McKearn JP; Smith WG
    Exp Hematol; 2001 Oct; 29(10):1177-84. PubMed ID: 11602319
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of thrombopoietin, interleukin-3 and the kinase inhibitor K-252a on growth and polyploidization of the megakaryocytic cell line M-07e.
    Quentmeier H; Zaborski M; Drexler HG
    Leukemia; 1998 Oct; 12(10):1603-11. PubMed ID: 9766506
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A non-peptide compound which can mimic the effect of thrombopoietin via c-Mpl.
    Kimura T; Kaburaki H; Tsujino T; Ikeda Y; Kato H; Watanabe Y
    FEBS Lett; 1998 May; 428(3):250-4. PubMed ID: 9654143
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thrombopoietin (TPO) induces tyrosine phosphorylation and activation of STAT5 and STAT3.
    Bacon CM; Tortolani PJ; Shimosaka A; Rees RC; Longo DL; O'Shea JJ
    FEBS Lett; 1995 Aug; 370(1-2):63-8. PubMed ID: 7544303
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thrombopoietin and its receptor.
    Wendling F; Vainchenker W
    Eur Cytokine Netw; 1998 Sep; 9(3):221-31. PubMed ID: 9831170
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thrombopoietin supports in vitro erythroid differentiation via its specific receptor c-Mpl in a human leukemia cell line.
    Yamada M; Komatsu N; Kirito K; Kashii Y; Tomizuka H; Okada K; Endo T; Fukumaki Y; Shinjo K; Abe K; Miura Y
    Cell Growth Differ; 1998 Jun; 9(6):487-96. PubMed ID: 9663467
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel MPL point mutation resulting in thrombopoietin-independent activation.
    Abe M; Suzuki K; Inagaki O; Sassa S; Shikama H
    Leukemia; 2002 Aug; 16(8):1500-6. PubMed ID: 12145691
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thrombopoietin induces tyrosine phosphorylation of Stat3 and Stat5 in human blood platelets.
    Miyakawa Y; Oda A; Druker BJ; Miyazaki H; Handa M; Ohashi H; Ikeda Y
    Blood; 1996 Jan; 87(2):439-46. PubMed ID: 8555464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Signal transduction by the peptide which mimics the activity of thrombopoietin.
    Kimura T; Kaburaki H; Tsujino T; Watanabe Y; Kato H
    Biochem Mol Biol Int; 1998 May; 44(6):1203-9. PubMed ID: 9623775
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recombinant human c-Mpl ligand (thrombopoietin) not only acts on megakaryocyte progenitors, but also on erythroid and multipotential progenitors in vitro.
    Tanimukai S; Kimura T; Sakabe H; Ohmizono Y; Kato T; Miyazaki H; Yamagishi H; Sonoda Y
    Exp Hematol; 1997 Sep; 25(10):1025-33. PubMed ID: 9293899
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thrombopoietin (c-mpl ligand) acts synergistically with erythropoietin, stem cell factor, and interleukin-11 to enhance murine megakaryocyte colony growth and increases megakaryocyte ploidy in vitro.
    Broudy VC; Lin NL; Kaushansky K
    Blood; 1995 Apr; 85(7):1719-26. PubMed ID: 7535585
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dissecting the thrombopoietin receptor: functional elements of the Mpl cytoplasmic domain.
    Drachman JG; Kaushansky K
    Proc Natl Acad Sci U S A; 1997 Mar; 94(6):2350-5. PubMed ID: 9122198
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.